Search
for
Sort by
Research 151–180 of 1000+
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Self-organization process in newborn skin organoid formation inspires strategy to restore hair regeneration of adult cells
- Janus kinase inhibitors for alopecia areata
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Pyruvate Kinase M2 Role in Cardiovascular Repair
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Comparative analysis of stemness between dermal papilla cells and human dermalstem/progenitor cells
- Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways
- TGF-β Family Signaling in Epithelial Differentiation and Epithelial–Mesenchymal Transition
- Phosphatidylinositol 3-Kinase/Akt-Dependent and -Independent Protection Against Apoptosis in Normal Human Melanocytes
- Flexural Agminated Eruptive Nevi in Langerhans Cell Histiocytosis
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- The Mixed Lineage Kinase Leucine-Zipper Protein Kinase Exhibits a Differentiation-Associated Localization in Normal Human Skin and Induces Keratinocyte Differentiation upon Overexpression
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Environmental Modulation of JAK3-Mediated Immune Dysregulation in Alopecia Areata